SCHEMBL14017690

SCHEMBL14017690

C[Si](C)(C)CNC(=O)/C(C#N)=C\C=C(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.44
LMNA P02545 7/20 0.42
PLIN1 O60240 1/20 0.42
PLIN5 Q00G26 1/20 0.42
ABHD5 Q8WTS1 1/20 0.42
HPGD P15428 4/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAOB P27338 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
MITF O75030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14486334 0.81 MTNR1A (0.45) HPGDGAAMEN1KMT2AALDH1A1
SCHEMBL2806467 0.79 LMNA (0.40) MCL1LMNAHPGDGAAMEN1
SCHEMBL2806471 0.79 LMNA (0.40) MCL1LMNAHPGDGAAMEN1
SCHEMBL13515693 0.78 SMN1; SMN2 (0.43) MCL1LMNAPLIN1PLIN5ABHD5
SCHEMBL14017685 0.77 MAOB (0.40) HPGDMEN1KMT2AALDH1A1MAPT
Malonic Acid SCHEMBL2415013 0.77 LMNA (0.39) MCL1LMNAHPGDGAAMEN1
SCHEMBL14017686 0.76 MAPT (0.41) HPGDGAAMEN1KMT2AALDH1A1
SCHEMBL14017688 0.75 DNM1 (0.39) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL1576555 0.75 LMNA (0.37) MCL1LMNAHPGDGAAMEN1
SCHEMBL12496025 0.75 LMNA (0.37) MCL1LMNAHPGDGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432386-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2008-10-07 US disclosed
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration L'OREAL 2007-09-13 US disclosed
US-7229609-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration CUTA, DDB1, DCLRE1A MCL1 3690/4885LMNA 1426/4885PLIN1 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.